Inhibition of ROCK2 expression protects against methamphetamine-induced neurotoxicity in PC12 cells

Brain Research

Volumn 1533, Issue , 2013, Pages 16-25

  Yang, Xingyi ^a   Liu, Yunyun ^b   Liu, Chao ^c   Xie, Weibing ^a   Huang, Enping ^a   Huang, Weiye ^a   Wang, Jiawen ^a   Chen, Ling ^a   Wang, Huipin ^a   Qiu, Pingming ^a   Xu, Jingtao ^a   Zhang, Fu ^a   Wang, Huijun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c Guangzhou Forensic Science Institute   (China)

Author keywords

Apoptosis; Methamphetamine; Neurotoxicity; Rho associated kinases II; Small interfering RNA

Indexed keywords

MESSENGER RNA; METHAMPHETAMINE; RHO ASSOCIATED KINASE 2; RHO KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRIGHT FIELD MICROSCOPY; CELL DAMAGE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; GENE SILENCING; GENE TARGETING; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

5-HT; 5-HYDROXYTRYPTAMINE; APOPTOSIS; DA; DOPAMINE; FITC; FLUORESCEIN ISOTHIOCYANATE; LIPO; LIPOFECTAMINE 2000; METH; METHAMPHETAMINE; NEUROTOXICITY; PARKINSON'S DISEASE; PD; RHO-ASSOCIATED KINASE II; RHO-ASSOCIATED KINASES II; ROCK2; SINC; SIRNA; SIROCK2; SMALL INTERFERING NONSPECIFIC CONTROL; SMALL INTERFERING RNA; SMALL INTERFERING RNA OF ROCK2; TH; TYROSINE HYDROXYLASE;

ANIMALS; APOPTOSIS; METHAMPHETAMINE; NEURONS; PC12 CELLS; RATS; RHO-ASSOCIATED KINASES;

EID: 84884592797     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.08.009     Document Type: Article

References (35)

1. S. Ares-Santos, N. Granado, I. Oliva, E. O'Shea, E.D. Martin, M.I. Colado, and R. Moratalla Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine Neurobiol. Dis. 45 2012 810 820
2. B.A. Bryan, E. Dennstedt, D.C. Mitchell, T.E. Walshe, K. Noma, R. Loureiro, M. Saint-Geniez, J.P. Campaigniac, J.K. Liao, and P.A. D'Amore RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis FASEB J. 24 2010 3186 3195
3. J.L. Cadet, S.V. Ordonez, and J.V. Ordonez Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2 Synapse 25 1997 176 184
4. M. Carvalho, H. Carmo, V.M. Costa, J.P. Capela, H. Pontes, F. Remiao, F. Carvalho, and M.L. Bastos Toxicity of amphetamines: an update Arch. Toxicol. 86 2012 1167 1231
5. D.R. Croft, and M.F. Olson Transcriptional regulation of Rho GTPase signaling Transcription 2 2011 211 215
6. R.W. Daniels, B.R. Miller, and A. DiAntonio Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration Neurobiol. Dis. 41 2011 415 420
7. X. Deng, Y. Wang, J. Chou, and J.L. Cadet Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method Mol. Brain Res. 93 2001 64 69
8. C. Deyts, B. Galan-Rodriguez, E. Martin, N. Bouveyron, E. Roze, D. Charvin, J. Caboche, and S. Betuing Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activation PLoS One 4 2009 e8287
9. N. Granado, S. Ares-Santos, and R. Moratalla Methamphetamine and Parkinson's disease Parkinsons Dis. 2013 2013 308052
10. N. Granado, S. Ares-Santos, I. Oliva, E. O'Shea, E.D. Martin, M.I. Colado, and R. Moratalla Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA Neurobiol. Dis. 42 2011 391 403
11. H. Hirata, B. Ladenheim, R.B. Rothman, C. Epstein, and J.L. Cadet Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals Brain Res. 677 1995 345 347
12. T. Iwazaki, I.S. McGregor, and I. Matsumoto Protein expression profile in the striatum of acute methamphetamine-treated rats Brain Res. 1097 2006 19 25
13. B.T. Jeon, E.A. Jeong, S.Y. Park, H. Son, H.J. Shin, D.H. Lee, H.J. Kim, S.S. Kang, G.J. Cho, W.S. Choi, and G.S. Roh The Rho-kinase (ROCK) inhibitor Y-27632 protects against excitotoxicity-induced neuronal death in vivo and in vitro Neurotoxic. Res. 23 2013 238 248
14. A. Khvorova, A. Reynolds, and S.D. Jayasena Functional siRNAs and miRNAs exhibit strand bias Cell 115 2003 209 216
15. T. Kita, I. Miyazaki, M. Asanuma, M. Takeshima, and G.C. Wagner Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity Int. Rev. Neurobiol. 88 2009 43 64
16. K. Legg Cell migration: an ABC of the RHO subfamily Nat. Rev. Mol. Cell Biol. 12 2011 403
17. L.Z. Li, H.J. Wang, J.W. Lan, X. Yue, and C. Liu Primary investigation of methamphetamine-induced toxicity in PC12 cells Nan Fang Yi Ke Da Xue Xue Bao 31 2011 39 43
18. X. Li, H. Wang, P. Qiu, and H. Luo Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain Neurochem. Int. 52 2008 256 264
19. Y. Li, Z. Hu, B. Chen, Q. Bu, W. Lu, Y. Deng, R. Zhu, X. Shao, J. Hou, J. Zhao, H. Li, B. Zhang, Y. Huang, L. Lv, Y. Zhao, and X. Cen Taurine attenuates methamphetamine-induced autophagy and apoptosis in PC12 cells through mTOR signaling pathway Toxicol. Lett. 215 2012 1 7
20. J.K. Liao, M. Seto, and K. Noma Rho kinase (ROCK) inhibitors J. Cardiovasc. Pharmacol. 50 2007 17 24
21. Y. Liu, Z. Liu, Y. Wang, Y.R. Liang, X. Wen, J. Hu, X. Yang, J. Liu, S. Xiao, and D. Cheng Investigation of the performance of PEG-PEI/ROCK-II-siRNA complexes for Alzheimer's disease in vitro Brain Res. 1490 2013 43 51
22. O. Nakagawa, K. Fujisawa, T. Ishizaki, Y. Saito, K. Nakao, and S. Narumiya ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice FEBS Lett. 392 1996 189 193
23. M. Narita, M. Takagi, K. Aoki, N. Kuzumaki, and T. Suzuki Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats J. Neurochem. 86 2003 273 282
24. R.J. Nichols, N. Dzamko, J.E. Hutti, L.C. Cantley, M. Deak, J. Moran, P. Bamborough, A.D. Reith, and D.R. Alessi Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease Biochem. J. 424 2009 47 60
25. M. Raad, T.T. El, R. Gul, S. Mondello, Z. Zhang, R.M. Boustany, J. Guingab, K.K. Wang, and F. Kobeissy Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma Electrophoresis 33 2012 3659 3668
26. M. Sasaki, K. Hashizume, S. Manaka, and K. Takakura The influences of neurotransmitters on the traumatic unconsciousness, immediate convulsion and mortality in the experimental mice model No To Shinkei 39 1987 983 990
27. K. Satoh, Y. Fukumoto, and H. Shimokawa Rho-kinase: important new therapeutic target in cardiovascular diseases Am. J. Physiol. Heart Circ. Physiol. 301 2011 H287 H296
28. M. Sebbagh, C. Renvoize, J. Hamelin, N. Riche, J. Bertoglio, and J. Breard Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing Nat. Cell Biol. 3 2001 346 352
29. M. Sebbagh, J. Hamelin, J. Bertoglio, E. Solary, and J. Breard Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner J. Exp. Med. 201 2005 465 471
30. J. Shi, and L. Wei Rho kinase in the regulation of cell death and survival Arch. Immunol. Ther. Exp. (Warsz) 55 2007 61 75
31. H. Shimokawa, and M. Rashid Development of Rho-kinase inhibitors for cardiovascular medicine Trends Pharmacol. Sci. 28 2007 296 302
32. N.R. Smalheiser The search for endogenous siRNAs in the mammalian brain Exp. Neurol. 235 2012 455 463
33. M. Surma, L. Wei, and J. Shi Rho kinase as a therapeutic target in cardiovascular disease Future Cardiol. 7 2011 657 671
34. Z. Yang, J. Wang, X. Liu, Y. Cheng, L. Deng, and Y. Zhong Y-39983 downregulates RhoA/Rho-associated kinase expression during its promotion of axonal regeneration Oncol. Rep. 29 2013 1140 1146
35. H. Ying, S.L. Biroc, W.W. Li, B. Alicke, J.A. Xuan, R. Pagila, Y. Ohashi, T. Okada, Y. Kamata, and H. Dinter The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models Mol. Cancer Ther. 5 2006 2158 2164